Astellas Pharma Inc.
ALPMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $31,237 | $17,045 | $132,361 | $156,886 |
| Dep. & Amort. | $199,132 | $157,840 | $105,738 | $79,684 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$166,369 | -$86,518 | -$24,209 | $5,956 |
| Other Non-Cash | $130,512 | $84,108 | $113,877 | $14,918 |
| Operating Cash Flow | $194,512 | $172,475 | $327,767 | $257,444 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$37,003 | -$38,056 | -$88,541 | -$76,448 |
| Net Acquisitions | $0 | -$784,974 | $0 | -$670 |
| Inv. Purchases | $0 | $0 | $0 | -$5,576 |
| Inv. Sales/Matur. | $12,920 | $0 | $12,624 | $5,576 |
| Other Inv. Act. | -$65,336 | -$22,772 | -$8,583 | $14,705 |
| Investing Cash Flow | -$89,419 | -$845,802 | -$84,500 | -$62,413 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$88,522 | $771,233 | -$15,000 | -$60,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$6,960 | -$10,735 | -$60,556 | -$50,717 |
| Dividends Paid | -$128,993 | -$116,653 | -$100,355 | -$85,236 |
| Other Fin. Act. | -$36,892 | -$29,785 | -$19,712 | -$20,345 |
| Financing Cash Flow | -$261,367 | $614,060 | -$195,623 | -$216,298 |
| Forex Effect | $8,960 | $18,113 | $13,210 | $11,125 |
| Net Chg. in Cash | -$147,315 | -$41,153 | $60,854 | -$10,142 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $335,687 | $376,840 | $315,986 | $326,128 |
| End Cash | $188,372 | $335,687 | $376,840 | $315,986 |
| Free Cash Flow | $137,182 | $89,978 | $239,226 | $180,996 |